Cisatracurium besylate
NDC 65145-135, Cisatracurium besylate, injection, from Caplin Steriles Limited.
- Product NDC
- 65145-135
- Status
- Listed
- Labeler
- Caplin Steriles Limited
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217725
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65145-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CISATRACURIUM BESYLATE2 mg/mL
Pharmacologic classes
Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65145-135-01 | 65145013501 | 1 VIAL, SINGLE-USE in 1 CARTON (65145-135-01) / 5 mL in 1 VIAL, SINGLE-USE |
| 65145-135-10 | 65145013510 | 10 VIAL, SINGLE-USE in 1 CARTON (65145-135-10) / 5 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/93101770-10a1-4bad-a762-289c793d8ace
Use it
Look up 65145-135 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65145-135 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65145-135. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.